241 related articles for article (PubMed ID: 7419370)
21. Treatment of the dry eye and related problems.
Barsam PC; Sampson WG; Feldman GL
Ann Ophthalmol; 1972 Feb; 4(2):122-6 passim. PubMed ID: 4400490
[No Abstract] [Full Text] [Related]
22. Current and future ophthalmic drug delivery systems. A shift to the posterior segment.
Del Amo EM; Urtti A
Drug Discov Today; 2008 Feb; 13(3-4):135-43. PubMed ID: 18275911
[TBL] [Abstract][Full Text] [Related]
23. [The use of chlorophyllypt in eye practice].
Tsvetkov VL; Shevchenko NF
Oftalmol Zh; 1972; 27(8):623-4. PubMed ID: 4658325
[No Abstract] [Full Text] [Related]
24. [Drugs for local use in ophthalmology].
Gonçalves Filho P; Feijò ND
Folha Med; 1965 Jun; 50(6):363-404. PubMed ID: 5850505
[No Abstract] [Full Text] [Related]
25. Advances in the treatment of allergic disorders of the eye.
Rohatgi JN; Singh HK; Siddiqui AA
Indian J Ophthalmol; 1982 Jul; 30(4):219-22. PubMed ID: 6820004
[No Abstract] [Full Text] [Related]
26. [Benzedrine collyrium. Further information on pupillary disorders].
Appelmans M
Arch Ophtalmol Rev Gen Ophtalmol; 1968 Sep; 28(6):633-9. PubMed ID: 4235613
[No Abstract] [Full Text] [Related]
27. Systemic reactions associated with ophthalmic medications.
Lama PJ
Ophthalmol Clin North Am; 2005 Dec; 18(4):569-84. PubMed ID: 16314220
[TBL] [Abstract][Full Text] [Related]
28. Tropicamide--a mydriatic cycloplegic in a West African eye clinic.
Zauberman H; Neuman E
Cent Afr J Med; 1970 Jan; 16(1):8-11. PubMed ID: 5418070
[No Abstract] [Full Text] [Related]
29. Soft lenses as therapeutic device.
Dada VK; Acharjee SC
Indian J Ophthalmol; 1982 Jul; 30(4):201-3. PubMed ID: 7166390
[No Abstract] [Full Text] [Related]
30. [Spersadex and Spersadex with chloramphenicol eyedrops].
Horven I
Tidsskr Nor Laegeforen; 1974 Apr; 94(12):789-90. PubMed ID: 4830344
[No Abstract] [Full Text] [Related]
31. A trial of 'lacribase', a new ophthalmic vehicle.
Maclure GM
Br J Clin Pract; 1967 Aug; 21(8):397-400. PubMed ID: 6076263
[No Abstract] [Full Text] [Related]
32. Pharmacology of ophthalmic drugs. Part III: Ocular decongestants, ocular lubricants & miscellaneous agents.
Goldstein J
J Ophthalmic Nurs Technol; 1987; 6(6):238-41. PubMed ID: 3694686
[No Abstract] [Full Text] [Related]
33. [Resistance of viruses in eye drops].
Korchmáros I; Nász I; Kulcsár G; Opauszki A; Dán P
Klin Monbl Augenheilkd; 1971 Mar; 158(3):409-12. PubMed ID: 4324776
[No Abstract] [Full Text] [Related]
34. Ophthalmic drug delivery: development and regulatory considerations.
Novack GD
Clin Pharmacol Ther; 2009 May; 85(5):539-43. PubMed ID: 19225448
[No Abstract] [Full Text] [Related]
35. Pathophysiology and pharmacology of anterior segment surgery.
Mishima S
Yan Ke Xue Bao; 1987 Sep; 3(3):143-7. PubMed ID: 3508398
[No Abstract] [Full Text] [Related]
36. Chitosan nanoparticles for drug delivery to the eye.
Paolicelli P; de la Fuente M; Sánchez A; Seijo B; Alonso MJ
Expert Opin Drug Deliv; 2009 Mar; 6(3):239-53. PubMed ID: 19290841
[TBL] [Abstract][Full Text] [Related]
37. Hyaluronan as an ophthalmic viscoelastic device.
Balazs EA
Curr Pharm Biotechnol; 2008 Aug; 9(4):236-8. PubMed ID: 18691081
[TBL] [Abstract][Full Text] [Related]
38. Ophthalmologic therapeutics.
Barish RA; Naradzay JF
Emerg Med Clin North Am; 1995 Aug; 13(3):649-67. PubMed ID: 7635087
[TBL] [Abstract][Full Text] [Related]
39. [New paradigms of ocular pharmacology].
Chast F
Ann Pharm Fr; 2011 Mar; 69(2):73-7. PubMed ID: 21440099
[No Abstract] [Full Text] [Related]
40. [Use of Sureptil drops in certain eye diseases].
Le Hunsec J
Bull Soc Ophtalmol Fr; 1972; 72(9):983-91. PubMed ID: 4666384
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
